Free Trial

ImmunityBio (IBRX) News Today

ImmunityBio logo
$2.54 +0.05 (+2.01%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$2.54 0.00 (-0.20%)
As of 05/2/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
ImmunityBio, Inc. stock logo
ImmunityBio (IBRX) to Release Quarterly Earnings on Thursday
ImmunityBio (NASDAQ:IBRX) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-immunitybio-inc-stock/)
ImmunityBio, Inc. stock logo
ImmunityBio (NASDAQ:IBRX) Stock Price Down 4.4% - Time to Sell?
ImmunityBio (NASDAQ:IBRX) Shares Down 4.4% - Here's Why
ImmunityBio, Inc. stock logo
ImmunityBio (NASDAQ:IBRX) Given Buy Rating at HC Wainwright
HC Wainwright reiterated a "buy" rating and issued a $8.00 target price on shares of ImmunityBio in a research note on Monday.
ImmunityBio, Inc. stock logo
Ghisallo Capital Management LLC Invests $1.28 Million in ImmunityBio, Inc. (NASDAQ:IBRX)
Ghisallo Capital Management LLC bought a new stake in ImmunityBio, Inc. (NASDAQ:IBRX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 500,000 shares of the company's stock, valued at appr
ImmunityBio, Inc. stock logo
ImmunityBio, Inc. (NASDAQ:IBRX) Shares Bought by LPL Financial LLC
LPL Financial LLC grew its position in ImmunityBio, Inc. (NASDAQ:IBRX - Free Report) by 67.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 257,449 shares of the company's stock after acquiring an additional 103,495 shares during the peri
ImmunityBio, Inc. stock logo
ImmunityBio (NASDAQ:IBRX) Receives Buy Rating from D. Boral Capital
D. Boral Capital reiterated a "buy" rating and set a $30.00 target price on shares of ImmunityBio in a report on Wednesday.
ImmunityBio, Inc. stock logo
JPMorgan Chase & Co. Sells 99,048 Shares of ImmunityBio, Inc. (NASDAQ:IBRX)
JPMorgan Chase & Co. lowered its stake in shares of ImmunityBio, Inc. (NASDAQ:IBRX - Free Report) by 8.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,041,863 shares of the company's stock after selling 99,048 shares
ImmunityBio, Inc. stock logo
Franklin Resources Inc. Lowers Position in ImmunityBio, Inc. (NASDAQ:IBRX)
Franklin Resources Inc. decreased its stake in ImmunityBio, Inc. (NASDAQ:IBRX - Free Report) by 54.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 88,686 shares of the company's st
ImmunityBio, Inc. stock logo
Q1 Earnings Forecast for ImmunityBio Issued By HC Wainwright
ImmunityBio, Inc. (NASDAQ:IBRX - Free Report) - Stock analysts at HC Wainwright dropped their Q1 2025 earnings per share (EPS) estimates for ImmunityBio in a research report issued on Wednesday, April 16th. HC Wainwright analyst A. Maldonado now anticipates that the company will post earnings per
ImmunityBio, Inc. stock logo
Altium Capital Management LLC Takes $2.71 Million Position in ImmunityBio, Inc. (NASDAQ:IBRX)
Altium Capital Management LLC acquired a new stake in shares of ImmunityBio, Inc. (NASDAQ:IBRX - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 1,060,000 shares of the company's stock, valued at approximately $2,714,000. Altium
ImmunityBio, Inc. stock logo
ImmunityBio (NASDAQ:IBRX) Stock Price Down 6.3% - Should You Sell?
ImmunityBio (NASDAQ:IBRX) Shares Down 6.3% - What's Next?
ImmunityBio, Inc. stock logo
ImmunityBio (NASDAQ:IBRX) Receives Buy Rating from HC Wainwright
HC Wainwright restated a "buy" rating and issued a $8.00 target price on shares of ImmunityBio in a research note on Wednesday.
ImmunityBio, Inc. stock logo
ImmunityBio (NASDAQ:IBRX) Shares Gap Up - Here's Why
ImmunityBio (NASDAQ:IBRX) Shares Gap Up - Here's Why
ImmunityBio, Inc. stock logo
ImmunityBio (NASDAQ:IBRX) Stock Price Up 7.8% - Here's What Happened
ImmunityBio (NASDAQ:IBRX) Trading 7.8% Higher - Should You Buy?
ImmunityBio, Inc. stock logo
ImmunityBio, Inc. (NASDAQ:IBRX) Stake Increased by Vanguard Group Inc.
Vanguard Group Inc. raised its stake in shares of ImmunityBio, Inc. (NASDAQ:IBRX - Free Report) by 2.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 17,328,229 shares of the company's stock after acquiring an additi
ImmunityBio, Inc. stock logo
ImmunityBio's (IBRX) Buy Rating Reaffirmed at D. Boral Capital
D. Boral Capital reaffirmed a "buy" rating and set a $30.00 price target on shares of ImmunityBio in a report on Wednesday.
ImmunityBio, Inc. stock logo
ImmunityBio (NASDAQ:IBRX) Stock Price Down 5.1% - What's Next?
ImmunityBio (NASDAQ:IBRX) Shares Down 5.1% - What's Next?
ImmunityBio: Taking Care Of Business
ImmunityBio, Inc. stock logo
D. Boral Capital Reaffirms Buy Rating for ImmunityBio (NASDAQ:IBRX)
D. Boral Capital reiterated a "buy" rating and issued a $30.00 price objective on shares of ImmunityBio in a research note on Monday.
ImmunityBio, Inc. stock logo
Corient Private Wealth LLC Has $569,000 Stock Holdings in ImmunityBio, Inc. (NASDAQ:IBRX)
Corient Private Wealth LLC trimmed its position in ImmunityBio, Inc. (NASDAQ:IBRX - Free Report) by 50.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 222,380 shares of the company's stock after selling 224,080 share
ImmunityBio, Inc. stock logo
ImmunityBio (NASDAQ:IBRX) Shares Down 8.9% - What's Next?
ImmunityBio (NASDAQ:IBRX) Shares Down 8.9% - What's Next?
ImmunityBio, Inc. stock logo
ImmunityBio (NASDAQ:IBRX) Stock Price Up 10.6% - What's Next?
ImmunityBio (NASDAQ:IBRX) Shares Up 10.6% - Here's What Happened
Top 10 Penny Stocks That Will Skyrocket
ImmunityBio to Host Investor Day
ImmunityBio, Inc. stock logo
Clearwater Capital Advisors LLC Acquires 363,870 Shares of ImmunityBio, Inc. (NASDAQ:IBRX)
Clearwater Capital Advisors LLC grew its holdings in ImmunityBio, Inc. (NASDAQ:IBRX - Free Report) by 75.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 846,419 shares of the company's stock after acquiring an addit
ImmunityBio, Inc. stock logo
ImmunityBio (IBRX) Expected to Announce Earnings on Tuesday
ImmunityBio (NASDAQ:IBRX) will be releasing earnings before the market opens on Tuesday, March 18, Financial Modeling Prep reports.
ImmunityBio, Inc. stock logo
ImmunityBio (NASDAQ:IBRX) Shares Down 2.9% - What's Next?
ImmunityBio (NASDAQ:IBRX) Trading Down 2.9% - Here's Why
ImmunityBio, Inc. stock logo
HC Wainwright Reaffirms Buy Rating for ImmunityBio (NASDAQ:IBRX)
HC Wainwright reaffirmed a "buy" rating and issued a $8.00 price objective on shares of ImmunityBio in a research note on Thursday.
ImmunityBio, Inc. stock logo
ImmunityBio (NASDAQ:IBRX) Stock Price Up 4.4% - Should You Buy?
ImmunityBio (NASDAQ:IBRX) Trading Up 4.4% - Should You Buy?
ImmunityBio announces 1st dosing of rBCG in U.S. and 60 sites pending
ImmunityBio, Inc. stock logo
ImmunityBio (NASDAQ:IBRX) Coverage Initiated by Analysts at HC Wainwright
HC Wainwright started coverage on ImmunityBio in a report on Thursday. They issued a "buy" rating and a $8.00 price objective for the company.
ImmunityBio initiated with a Buy at H.C. Wainwright
ImmunityBio, Inc. stock logo
ImmunityBio (NASDAQ:IBRX) Trading Up 6.8% on Strong Earnings
ImmunityBio (NASDAQ:IBRX) Trading Up 6.8% After Earnings Beat
Get ImmunityBio News Delivered to You Automatically

Sign up to receive the latest news and ratings for IBRX and its competitors with MarketBeat's FREE daily newsletter.

IBRX Media Mentions By Week

IBRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IBRX
News Sentiment

0.39

0.73

Average
Medical
News Sentiment

IBRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IBRX Articles
This Week

6

4

IBRX Articles
Average Week

Get ImmunityBio News Delivered to You Automatically

Sign up to receive the latest news and ratings for IBRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:IBRX) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners